Last synced on 18 April 2025 at 11:05 pm

Stent, Urethral, Prostatic, Semi-Permanent

Page Type
Product Code
Definition
Approximately 3 cm tube placed in the prostatic urethra for short term use to drain urine. The device includes a retention mechanism that anchors in the bladder neck to hold it in place and a release mechanism that exits the penis. For short term use in men with partial of full prostatic urethral obstruction or the prevention of prostatic urethral obstruction post surgery or other prostatic treatment.
Physical State
Approximately 3 centimeter tube (i.e. length of prostatic urethra) that is inserted into the prostatic urethra and includes a proximal retention component that anchors the device in the bladder neck and a suture-type material on the distal end that exits the urethra.
Technical Method
The urethral stent crosses a partially or fully obstructed prostatic urethra to allow passage of urine.
Target Area
Prostatic urethra.
Review Panel
Gastroenterology and Urology
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code NZC to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.

Stent, Urethral, Prostatic, Semi-Permanent

Page Type
Product Code
Definition
Approximately 3 cm tube placed in the prostatic urethra for short term use to drain urine. The device includes a retention mechanism that anchors in the bladder neck to hold it in place and a release mechanism that exits the penis. For short term use in men with partial of full prostatic urethral obstruction or the prevention of prostatic urethral obstruction post surgery or other prostatic treatment.
Physical State
Approximately 3 centimeter tube (i.e. length of prostatic urethra) that is inserted into the prostatic urethra and includes a proximal retention component that anchors the device in the bladder neck and a suture-type material on the distal end that exits the urethra.
Technical Method
The urethral stent crosses a partially or fully obstructed prostatic urethra to allow passage of urine.
Target Area
Prostatic urethra.
Review Panel
Gastroenterology and Urology
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code NZC to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.